Protalix BioTherapeutics Inc - Company Profile

Powered by

All the data and insights you need on Protalix BioTherapeutics Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Protalix BioTherapeutics Inc Strategy Report

  • Understand Protalix BioTherapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Protalix BioTherapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Protalix BioTherapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Protalix BioTherapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Eliot Richard Forster

Chairman Executive Board Since: 2023

Mr. Eliot Richard Forster has been the Chairman of the company since September 2023. Prior to this, he served as a Chief Executive Officer of F-Star Therapeutics Ltd. Prior to that, he served as Chief Executive Officer of Immunocure Ltd., Chief Executive Officer of Creabilis SA and President and Chief Executive Officer of Solace Pharmaceuticals Inc.

Read Hide full bio of Eliot Richard Forster

Dror Bashan

Chief Executive Officer; Director; President Executive Board Since: 2019 Age: 56

Mr. Dror Bashan has been the Chief Executive Officer, the President and a Director of the company since 2019. He has 20 years of experience in the pharmaceutical industry. Prior to this, he served various senior positions at Teva Pharmaceutical Industries Ltd.

Read Hide full bio of Dror Bashan

Eyal Rubin

Chief Financial Officer; Senior Vice President Senior Management Since: 2019 Age: 47

Mr. Eyal Rubin has been the Senior Vice President and the Chief Financial Officer of the company since 2019. He has 20 years of experience in finance and capital markets. Previously, he served as the Executive Vice President and the Chief Financial Officer at BrainStorm Cell Therapeutics Inc.

Read Hide full bio of Eyal Rubin

Raul Chertkoff, M.D

Senior Advisor Senior Management Since: 2022

Yael Hayon, Ph.D.

Vice President - Research & Development Senior Management Since: 2020 Age: 40
Gain a 360-degree view of Protalix BioTherapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Protalix BioTherapeutics Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer